Alzheimer's Disease Diagnostics Market, Report By Type, By Diagnostic Technique, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

The Alzheimer's disease Diagnostics Market size was valued at US$ 9,2190.10 Million in 2024, expanding at a CAGR of 11.19% from 2025 to 2032.

The global Alzheimer's disease diagnostics market is witnessing steady growth due to the rising prevalence of neurodegenerative disorders, the increasing ageing population, and growing awareness regarding early diagnosis. Technological advancements in biomarker-based testing, neuroimaging, and blood-based diagnostics are improving detection accuracy and enabling earlier intervention. Supportive government initiatives, increased research funding, and expanding access to diagnostic services are further contributing to market growth across both developed and emerging economies.

Alzheimer's Disease Diagnostics Market- Market Dynamics

Rising prevalence of Alzheimer's disease and an ageing population

The increasing global geriatric population and the rising incidence of Alzheimer's disease are key drivers fueling demand for advanced diagnostic solutions. Early and accurate diagnosis is essential for effective disease management, timely treatment planning, and improving patient quality of life. For instance, in January 2025, the European Brain Council reported that nearly 7 million people across Europe are currently living with Alzheimer's disease, and with an ageing population, this number is projected to rise to approximately 14 million by 2030, highlighting the growing public health burden of the disease. Advancements in diagnostic technologies, including biomarker-based assays and non-invasive neuroimaging techniques, combined with increasing awareness among healthcare professionals, are accelerating diagnostic adoption. In parallel, continuous R&D investments by diagnostic companies are strengthening product pipelines and expanding global diagnostic capabilities.

Alzheimer's disease Diagnostics Market- Segmentation Analysis:

The Global Alzheimer's Disease Diagnostics Market is segmented on the basis of Type, Diagnostic Technique, End User, and Region.

Based on Type, the market is categorised into Early-Onset Alzheimer's Disease and Late-Onset Alzheimer's Disease. Late-onset Alzheimer's disease holds a dominant share due to its higher prevalence among the elderly population. Additionally, the rising global geriatric population and increased life expectancy significantly contribute to the growing number of late-onset cases. Improved diagnostic awareness and higher healthcare utilisation among older adults further reinforce the dominance of this segment in the market.

Based on the diagnostic technique, the market is categorised into Neuroimaging, Biomarker Tests, Genetic Testing, Cognitive Tests, and Others. Neuroimaging and biomarker-based diagnostics account for a significant share owing to their high diagnostic accuracy and growing clinical adoption. Advancements in imaging technologies and biomarker discovery have enabled earlier and more reliable detection of Alzheimer's disease. Furthermore, increasing investments in precision medicine and the integration of these techniques into clinical trials are driving their widespread use..

Based on End User, the market is categorised into Hospitals & Clinics, Diagnostic Laboratories, Research Institutes, and Others. Hospitals and diagnostic laboratories dominate due to high patient inflow and access to advanced diagnostic infrastructure. These settings also benefit from the availability of skilled healthcare professionals and integrated diagnostic services, enabling timely and accurate disease detection. Additionally, rising hospital-based screening programs and referrals further strengthen their market dominance.

Alzheimer's Disease Diagnostics Market- Geographical Insights

North America holds the leading position in the Alzheimer's disease diagnostics market, attributed to its advanced healthcare infrastructure, high levels of public awareness, and rapid adoption of innovative diagnostic technologies. These factors facilitate early detection and timely intervention, which are crucial in managing Alzheimer's disease effectively. Europe follows closely, bolstered by well-established research facilities and supportive government healthcare policies that encourage investment in new diagnostic methodologies and technologies. In the Asia-Pacific region, anticipated rapid growth is driven by a significantly ageing population, coupled with improving healthcare access and increasing investments in diagnostic infrastructure, particularly in major markets like China and India. These nations are prioritising the enhancement of their healthcare systems to address the rising prevalence of Alzheimer's. Meanwhile, Latin America and the Middle East & Africa are experiencing gradual growth as public awareness around Alzheimer's improves, alongside advancements in diagnostic capabilities, ultimately contributing to better patient management and outcomes in these regions.

Alzheimer's Disease Diagnostics Market- Country Insights

The United States maintains a dominant position in the Alzheimer's disease diagnostics market, attributable to its high utilisation of diagnostic tests, robust reimbursement frameworks that facilitate patient access to cutting-edge technologies, and the presence of leading diagnostic companies driving innovation. These factors create a conducive environment for the rapid development and adoption of new diagnostic methods. In Europe, Germany, the UK, and France play significant roles, benefiting from their advanced healthcare systems that promote high-quality care and ongoing research activities aimed at enhancing diagnostic accuracy and developing novel testing solutions. Meanwhile, China and India are emerging as high-growth markets, fueled by their large patient populations and expanding diagnostic networks that enhance accessibility to essential services. Additionally, both countries are increasingly focusing on early disease detection, aligning with global trends that emphasize proactive healthcare measures. This combination of factors positions them favorably for accelerated growth in the diagnostic landscape, contributing to improving outcomes for patients with Alzheimer's disease.

Alzheimer's disease Diagnostics Market- Competitive Landscape:

The Alzheimer's disease diagnostics market is moderately competitive, with key players prioritizing technological innovation, biomarker development, and strategic collaborations to strengthen their market presence. For instance, August 2025: BGI Genomics developed an in-house blood-based diagnostic test for Alzheimer's disease and other cognitive disorders, following China's national regulatory approval received in April 2024. The test analyses five key blood-based biomarkers, including specific tau and amyloid protein variants, as well as additional neuro-related indicators, providing clinicians with a more comprehensive understanding of underlying brain pathology. Furthermore, ongoing clinical trials for investigational diagnostic tools and novel biomarkers continue to support innovation and are significantly accelerating overall market growth. Companies are increasingly investing in advanced blood-based tests, imaging solutions, and AI-enabled diagnostic tools aimed at improving early detection and clinical outcomes. Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers are prominent leaders in this space, leveraging their extensive research capabilities to develop cutting-edge diagnostic technologies. GE HealthCare and Fujirebio specialise in advanced imaging techniques and biomarker assays, further advancing diagnostic accuracy. Additionally, Biogen and Quanterix focus on innovative therapies and diagnostic solutions to address the complexities of Alzheimer's. C2N Diagnostics, Thermo Fisher Scientific, and Danaher Corporation also contribute significantly, providing specialized tools and technologies for early detection. Together, these companies shape a dynamic landscape that is critical for enhancing understanding and management of Alzheimer's disease through improved diagnostic capabilities.

Recent Developments:

On May 16, 2025, the FDA cleared the first in vitro blood test to aid in the diagnosis of Alzheimer's disease. Developed by Fujirebio Diagnostics, Inc., the Lumipulse G pTau217 / B-Amyloid 1-42 Plasma Ratio is designed to detect amyloid plaques in adults aged 55 and older who exhibit symptoms of cognitive impairment.

In August 2025, C2N Diagnostics, LLC announced a major global expansion of its PrecivityAD2 blood test, reaching additional healthcare providers across Asia, Europe, Latin America, and the Middle East. This initiative aims to broaden access to high-precision Alzheimer's disease diagnostics, particularly in regions with limited imaging infrastructure.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories
Roche Diagnostics
Siemens Healthineers
GE HealthCare
Fujirebio
Biogen
Quanterix
C2N Diagnostics
Thermo Fisher Scientific
Danaher Corporation
Others

GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

Early-Onset Alzheimer's Disease
Late-Onset Alzheimer's Disease
Others

GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY DIAGNOSTIC TECHNIQUE ANALYSIS, 2019 - 2032

Neuroimaging
Biomarker Tests
Genetic Testing
Cognitive Tests
Others

GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

Hospitals & Clinics
Diagnostic Laboratories
Research Institutes
Others

GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5952

1. Alzheimer's Disease Diagnostics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Alzheimer's Disease Diagnostics Market Snippet by Type
- 2.1.2. Alzheimer's Disease Diagnostics Market Snippet by Diagnostic Technique
- 2.1.3. Alzheimer's Disease Diagnostics Market Snippet by End User
- 2.1.4. Alzheimer's Disease Diagnostics Market Snippet by Country
- 2.1.5. Alzheimer's Disease Diagnostics Market Snippet by Region
2.2. Competitive Insights

3. Alzheimer's Disease Diagnostics Key Market Trends

3.1. Alzheimer's Disease Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Alzheimer's Disease Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Alzheimer's Disease Diagnostics Market Opportunities
3.4. Alzheimer's Disease Diagnostics Market Future Trends

4. Alzheimer's Disease Diagnostics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Alzheimer's Disease Diagnostics Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Alzheimer's Disease Diagnostics Market Landscape

6.1. Alzheimer's Disease Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Alzheimer's Disease Diagnostics Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
- 7.1.2. Early-Onset Alzheimer's Disease
- 7.1.3. Late-Onset Alzheimer's Disease
- 7.1.4. Others

8. Alzheimer's Disease Diagnostics Market - By Diagnostic Technique

8.1. Overview
- 8.1.1. Segment Share Analysis, By Diagnostic Technique, 2024&2032 (%)
- 8.1.2. Neuroimaging
- 8.1.3. Biomarker Tests
- 8.1.4. Genetic Testing
- 8.1.5. Cognitive Tests
- 8.1.6. Others

9. Alzheimer's Disease Diagnostics Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2024&2032 (%)
- 9.1.2. Hospitals & Clinics
- 9.1.3. Diagnostic Laboratories
- 9.1.4. Research Institutes
- 9.1.5. Others

10. Alzheimer's Disease Diagnostics Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Alzheimer's Disease Diagnostics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
- 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
- 10.2.5. North America Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
- 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.2.7.4. U.S. Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.2.8.4. Canada Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Alzheimer's Disease Diagnostics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
- 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
- 10.3.5. Europe Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
- 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.3.7.4. Germany Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.3.8.4. UK Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.3.9.4. France Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.3.10.4. Italy Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.3.11.4. Spain Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.3.13.4. Sweden Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.3.14.4. Russia Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.3.15.4. Poland Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.16. Rest of Europe
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.3.16.4. Rest of the Europe Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Alzheimer's Disease Diagnostics Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
- 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
- 10.4.5. APAC Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
- 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.4.7.4. China Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.4.8.4. India Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.4.9.4. Japan Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.4.10.4. South Korea Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.4.11.4. Australia Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.4.13.4. Thailand Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.14.3. PhilippinesMarket Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.4.14.4. Philippines Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Alzheimer's Disease Diagnostics Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
- 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
- 10.5.5. LATAM Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
- 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.5.7.4. Brazil Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.5.8.4. Mexico Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.5.9.4. Argentina Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.5.10.4. Colombia Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Alzheimer's Disease DiagnosticsKey Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
- 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
- 10.6.5. MEA Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
- 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.6.8.4. UAE Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.6.9.4. Israel Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.6.10.4. Turkey Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.6.11.4. Algeria Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.6.12.4. Egypt Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Alzheimer's Disease Diagnostics Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Abbott Laboratories
- 11.2.2. Roche Diagnostics
- 11.2.3. Siemens Healthineers
- 11.2.4. GE HealthCare
- 11.2.5. Fujirebio
- 11.2.6. Biogen
- 11.2.7. Quanterix
- 11.2.8. C2N Diagnostics
- 11.2.9. Thermo Fisher Scientific
- 11.2.10. Danaher Corporation
- 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us